This federal contract award, valued at $3,278.21, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Jardiance 10 mg tablets, a pharmaceutical product, to support medical operations for the U.S. Armed Forces.
Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This contract enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to the Defense Logistics Agency. The current award, with a completion date of December 23, 2024, is a firm fixed-price delivery order under this larger IDC vehicle. The contract does not have a set-aside designation.
Generated 3/21/25, 9:47 AM